Nicholas B. Argento

Glycemic Effects Of Sglt-2 Inhibitor Canagliflozin In Type 1 Diabetes Patients Using The Dexcom G4 Platinum Cgm

Nicholas B. Argento, Katherine Nakamura · Endocrine Practice · 2015 · 23 citations

Medicine, Endocrinology, Pharmacology +15

EMBARK: A Randomized, Controlled Trial Comparing Three Approaches to Reducing Diabetes Distress and Improving HbA1c in Adults With Type 1 Diabetes

Danielle Hessler, Lawrence Fisher, Susan Guzman et al. · Diabetes Care · 2024 · 23 citations · Full text

Medicine, Internal Medicine, Diabetology +9

Personal Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older

Nicholas B. Argento, Katherine Nakamura · Endocrine Practice · 2014 · 20 citations

Medicine, Geriatric Medicine, Internal Medicine +13

Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes

Nicholas B. Argento, Jingwen Liu, Allyson S. Hughes et al. · Journal of Diabetes Science and Technology · 2019 · 17 citations · Full text

Public Affairs, Health Policy, Health Services Administration +16

Hemoglobin A1C, Mean Glucose, and Persistence of Glycation Ratios in Insulin-Treated Diabetes

Nicholas B. Argento, Katherine Nakamura, Robert D. Sala et al. · Endocrine Practice · 2013 · 11 citations

Medicine, Biochemistry, Endocrinology +17